Amplifon, a large Italian retailer of hearing aids, is expecting its first marketed products to be sold without a prescription in the US during the second half of 2022, the company revealed during its capital markets day on Monday.
The hearing healthcare company's expectation is that the proposed regulations on the OTC market, which would enable over-the-counter sales of hearing aids to adults with mild to moderate hearing loss – sidestepping an appointment with an audiologist – willl be presented by the US Food and Drug Administration (FDA) in November.
Hereafter, there will be a short window for industry objections and recommendations, before approximately six months of implementation commence.
The timeline therefore fits with the executive order that President Joe Biden signed at the beginning of July, which sent ripples through the hearing aid market.
In the order, Biden criticized the prices of hearing aids, which he thinks have become too expensive for US families. He therefore directed the FDA to propose rules for the over-the-counter sales of hearing aids within 120 days.
Italian hearing aid retailer disappoints with growth prognosis
New GN device to open giant market for mild hearing loss
Hearing industry challenger applauds Biden's price battle
New Biden order criticizing hearing aid expense causes falling share prices
More from MedWatch
CHMP to remove 100 generic medicines from market
Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.
Germany orders 40,000 monkeypox vaccines from Bavarian Nordic
The German Minister for Health has revealed that the German state has ordered vaccines from Bavarian Nordic, as the country reports 5 cases of monkeypox.
New head of research at Astellas Gene Therapies: "Choosing the right indications is extra important"
Morten Søgaard is leaving Pfizer to join Astellas, where he will be in charge of 100 employees. Going from one of the world largest pharmaceutical firms to a considerably smaller one will be a challenge, he says.
Rumored purchase of GN Group could mean divestment of hearing aid division, says media
Inside Business has learned that a number of buyers might be looking to buy GN Store Nord stock while it’s cheap, with the plan to sell one division, GN Hearing, while keeping Audio.
EMA publishes new plan to support antibiotic development
Drug-resistant bacteria kill hundreds of thousands of people every year, and national regulatory forces across the world are now coming together to ensure a uniform approach to clinical trials for antibiotics.
Project Manager & Scrum Master 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
Senior Project Manager (GMP - Life Science) 
Senior Manager, Clinical Trial Budget 
Clinical Trial Administrator 
Cell Culture Scientist/Senior Scientist 
Nordic Medical Affairs Manager 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Consultant Manager 
Account Manager 
Strategic Procurement Manager, Direct Spend (Category Manager) 
Clinical Trial Manager 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
SAP System Specialist (Product Supply) – Business Application Services 
Client Talent Acquisition Specialist 
Production Director